Rowles, Susannah
-
British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Survey
ABCD Survey: Life as a diabetologist during the COVID-19 pandemic
Abstract PDF HTML -
British Journal of Diabetes Vol. 19 No. 2 (2019): DECEMBER 2019 - Original Research
Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit
Abstract PDF HTML -
British Journal of Diabetes Vol. 21 No. 2 (2021): December 2021 - Survey
Integrated diabetes care: The Association of British Clinical Diabetologists (ABCD) national survey report
Abstract PDF HTML -
British Journal of Diabetes Vol. 22 No. 1 (2022): June 2022 - Current Topics
Dapagliflozin use in type 1 diabetes: industry, business and ethics
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - ABCD News
ABCD, YDEF and DTN-UK News
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Position Statements
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020)
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
The effect of dapagliflozin on alanine aminotransferase as a marker of liver inflammation: updated results from the ABCD dapagliflozin audit
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine)
Abstract PDF HTML
